These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8018455)

  • 1. Isolated circulatory response to intravenous administration of the ACE inhibitor enalaprilat.
    Boldt J; Knothe C; Schindler F; Stertmann WA; Hempelmann G
    Br J Clin Pharmacol; 1994 Apr; 37(4):341-6. PubMed ID: 8018455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients.
    Boldt J; Schindler E; Härter K; Görlach G; Hempelmann G
    Anesth Analg; 1995 Mar; 80(3):480-5. PubMed ID: 7864411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients.
    Boldt J; Schindler E; Wollbrück M; Görlach G; Hempelmann G
    J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):44-49. PubMed ID: 7718754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition has no effect on blood pressure and splanchnic perfusion after cardiac surgery.
    Parviainen I; Rantala A; Ruokonen E; Tenhunen J; Takala J
    J Crit Care; 1998 Jun; 13(2):73-80. PubMed ID: 9627274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous i.v. administration of the angiotensin-converting enzyme inhibitor enalaprilat in the critically ill: effects on regulators of circulatory homeostasis.
    Boldt J; Menges T; Wollbrück M; Härter K; Hempelmann G
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):416-23. PubMed ID: 7769807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulatory effects of the PDE-inhibitors piroximone and enoximone.
    Boldt J; Knothe C; Zickmann B; Schindler E; Stertmann WA; Hempelmann G
    Br J Clin Pharmacol; 1993 Oct; 36(4):309-14. PubMed ID: 12959308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary actions of intravenously administered enalaprilat in trauma patients.
    Boldt J; Menges T; Wollbrück M; Hammermann H; Hempelmann G
    Crit Care Med; 1994 Jun; 22(6):960-4. PubMed ID: 8205828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local forearm vasodilation with intra-arterial administration of enalaprilat in humans.
    Bank AJ; Kubo SH; Rector TS; Heifetz SM; Williams RE
    Clin Pharmacol Ther; 1991 Sep; 50(3):314-21. PubMed ID: 1655327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery.
    Türker H; Dönmez A; Zeyneloğlu P; Sezgin A; Uluçam M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):296-300. PubMed ID: 15590356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorespiratory effects of continuous i.v. administration of the ACE inhibitor enalaprilat in the critically ill.
    Boldt J; Müller M; Heesen M; Härter K; Hempelmann G
    Br J Clin Pharmacol; 1995 Nov; 40(5):415-22. PubMed ID: 8703644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of i.v. enalaprilat in chronically treated hypertensive patients during cardiac surgery.
    Schuetz WH; Lindner KH; Georgieff M; Mueller S; Oertel F; Radermacher P; Gauss A
    Acta Anaesthesiol Scand; 1998 Sep; 42(8):929-35. PubMed ID: 9773137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
    Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
    Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute administration of metoprolol and enalaprilat reduces insulin-stimulated thermogenesis and skin blood flow.
    Tuominen JA; Eriksson JG; Koivisto VA
    J Intern Med; 1996 May; 239(5):399-406. PubMed ID: 8642232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.
    Ryckwaert F; Colson P; André E; Perrigault PF; Guillon G; Barberis C
    Br J Anaesth; 2002 Oct; 89(4):599-604. PubMed ID: 12393362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and regional hemodynamic effects of enalaprilat infusion in experimental normotensive sepsis.
    Rahal L; Garrido AG; Cruz RJ; Rocha e Silva M; Poli-de-Figueiredo LF
    Braz J Med Biol Res; 2006 Sep; 39(9):1205-15. PubMed ID: 16981048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic central administration of enalaprilat lowers blood pressure in stroke-prone spontaneously hypertensive rats.
    Jablonskis LT; Rogers PF; Lungershausen YK; Howe PR
    J Auton Nerv Syst; 1992 Jun; 39(2):119-26. PubMed ID: 1331222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
    Richer C; Doussau MP; Giudicelli JF
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):865-72. PubMed ID: 2562138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.